Versant Capital Management’s iRadimed IRMD Stock Holding History

Versant Capital Management’s Portfolio IRMD Stock Details IRMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$8.97K	Hold	104	–	–	﹤0.01%	2297
2026 Q2	$9.9K	Hold	104	–	–	﹤0.01%	2235
2026 Q1	$10K	Hold	104	–	–	﹤0.01%	2143
2025 Q4	$10.1K	Hold	104	–	–	﹤0.01%	1987
2025 Q3	$7.4K	Hold	104	–	–	﹤0.01%	2058
2025 Q2	$6.22K	Hold	104	–	–	﹤0.01%	2083
2025 Q1	$5.46K	Hold	104	–	–	﹤0.01%	1999
2024 Q4	$5.72K	Buy	+104	New	+$5.47K	﹤0.01%	1697

Other funds holding IRMD

Copeland Capital Management Conshohocken, Pennsylvania $4.34B AUM 17.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Ranger Investment Management Dallas, Texas $1.07B AUM 31.98% 1-Year Est. Return

Bridge City Capital Lake Oswego, Oregon $480M AUM 47.16% 1-Year Est. Return

Shaker Investments Cleveland, Ohio $268M AUM 52.46% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Russell Investments Group London, United Kingdom $114B AUM 33.83% 1-Year Est. Return

Davidson Capital Management Corpus Christi, Texas $604M AUM 18.09% 1-Year Est. Return

Oak Ridge Investments Chicago, Illinois $1.68B AUM 48.52% 1-Year Est. Return

Versant Capital Management's IRMD Position: Q3 2026 in Review

Versant Capital Management held its iRadimed (IRMD) position steady in Q3 2026 at 104 shares worth $8.97K. The position accounts for ﹤0.01% of the portfolio, ranked #2297.

Versant Capital Management first reported a position in IRMD in Q4 2024 and has held it in 8 quarters since. The position peaked at $10.1K in Q4 2025. 79 funds tracked by Wall St. Rank hold IRMD as of Q3 2026.

Versant Capital Management held 104 shares of iRadimed worth $8.97K as of Q3 2026.
Versant Capital Management left its iRadimed share count unchanged in Q3 2026.
iRadimed made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2297 holding.
Versant Capital Management first reported a position in iRadimed in Q4 2024 and has held it in 8 quarters since.
Versant Capital Management's iRadimed position peaked at $10.1K in Q4 2025.
79 funds tracked by Wall St. Rank held iRadimed as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.